News
20 September 2016
Strengthening gene therapy for Huntington’s disease
A single injection of a new treatment has reduced the activity of the gene responsible for Huntington’s disease for several months in a trial in mice.
20 September 2016
"Dedos de Zinc, una posible solución a la enfermedad de Huntington" (CRG / Diario Médico)
"Dedos de Zinc, una posible solución a la enfermedad de Huntington" (CRG / Diario Médico)
20 September 2016
"Una inyección reduce la enfermedad de Huntington en ratones durante varios meses" (CRG / La Vanguardia.com)
"Una inyección reduce la enfermedad de Huntington en ratones durante varios meses" (CRG / La Vanguardia.com)
15 September 2016
"The long-sought cure to Huntington's disease" (CRG / Cordis)
"The long-sought cure to Huntington's disease" (CRG / Cordis)
15 September 2016
The long-sought cure to Huntington's disease (CRG / Cordis)
The long-sought cure to Huntington's disease (CRG / Cordis)
14 September 2016
The Science to Business (S2B) Concept Challenge fosters again the CRG entrepreneurial spirit
The second edition of the Science to Business (S2B) Concept Challenge is open and ready to receive new ideas...
8 September 2016
"The long-sought cure to Huntington's disease" (CRG / Research EU Results Magazine)
"The long-sought cure to Huntington's disease" (CRG / Research EU Results Magazine)
8 September 2016
The long-sought cure to Huntington's disease (CRG / Research EU Results Magazine)
The long-sought cure to Huntington's disease (CRG / Research EU Results Magazine)
1 July 2016
CRG Proof of Concept: Commercialization Gap Fund (CGF)
Deadline (Short Submission): 01/09/2016
Please send your application (max. 2 pages) under the following schemes:
- MIDI - Up to 6 months and 35 kEUR
- MAXI - Up to 12 months and 75 kEUR
1 July 2016
3rd CRG BioBusiness School (Extended Deadline)
12th-16th September 2016
Based on the great success of the former editions, the 3rd CRG Bio-Business School shall:
- Raise awareness about technology transfer among the participants through lectures and hands-on practical sessions;
- Teach the challenges, opportunities and tools to successfully transfer basic knowledge "from the lab to the marketplace";
- Identify projects with technology transfer/business potential that could otherwise remain undisclosed;
- Match basic science in biomedicine, bioinformatics, etc. with business;
- Have participants function as "signal amplifiers", able to spread the knowledge acquired amongst other colleagues, and apply it to new projects;
- Stimulate a culture of innovation and entrepreneurship.
Registration is free and open online. Click here to register. Deadline (extended) 08 July2016